Evaluation of RTVue XR With SSADA

Clinical Evaluation of RTVue XR With SSADA in Retinal Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02535520

Enrollment

155

Registered

2015-08-28

Start date

2015-08-31

Completion date

2015-12-31

Last updated

2016-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retina Vascular Pathology

Brief summary

Optovue has implemented a motion contrast imaging software in RTVue XR, a split spectrum amplitude decorrelation algorithm (SSADA), for non-invasive imaging of ocular vasculature. Consented subjects will undergo a series of images of the back of the eye using an Optical Coherence Tomograpy (OCT) device, RTVue XR, in addition to the conventional images as part of clinical routine. SSADA images will be compared with conventional methods.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \>18 * Able and willing to complete exams * Patients in retina clinic that need angiography

Exclusion criteria

* Unable to complete the required examinations and visits * Large amount of subretinal hemorrhage * Media opacity leading to poor quality images * Extreme refractive error leading to poor quality images * Pathologies in the anterior segment leading to poor quality images

Design outcomes

Primary

Measure	Time frame
Agreement of SSADA to conventional angiography	Day 1

Outcome results